openPR Logo
Press release

Global Drivers Analysis: The Rapid Evolution of the Companion Animal Pharmaceuticals Market

04-07-2026 08:56 AM CET | Health & Medicine

Press release from: The Business Research Company

Companion Animal Pharmaceuticals Market

Companion Animal Pharmaceuticals Market

The companion animal pharmaceuticals sector is on track for remarkable growth as pet healthcare continues to advance and evolve. Innovations in treatment options and expanding veterinary services are driving strong demand worldwide, reflecting the growing importance of specialized medicines for pets. Let's explore the market's valuation, key players, emerging trends, and segment breakdowns shaping this dynamic industry.

Forecasted Market Value and Growth in Companion Animal Pharmaceuticals
The companion animal pharmaceuticals market is projected to reach $29.14 billion by 2030, expanding at an impressive compound annual growth rate (CAGR) of 10.3%. This surge is propelled by developments in precision medicine tailored for companion animals, wider utilization of digital prescription management systems, and the growing emphasis on preventive healthcare including vaccination programs. Additionally, there is increasing demand for specialized therapeutics targeting behavioral and orthopedic conditions, alongside the growing veterinary retail pharmacy networks that enhance accessibility. Key trends fueling this growth include rising interest in companion animal vaccines, a boost in the use of anti-inflammatory and pain management medications, expansion of behavioral and dermatologic treatments, and more customized drug formulations specific to different pet species.

Download a free sample of the companion animal pharmaceuticals market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7983&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Companies Steering the Companion Animal Pharmaceuticals Market
The industry features several prominent players shaping the landscape, including Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Inovet Group, Merck & Co. Inc., Norbrook Laboratories Ltd., Vetoquinol S.A., Virbac S.A., Zoetis Inc., Eli Lilly and Company, IDEXX Laboratories Inc., Merial Limited, Dechra Pharmaceuticals PLC, Aratana Therapeutics Inc., Kindred Biosciences Inc., Jaguar Health Inc., Nexvet Biopharma PLC, PetMed Express Inc., Heska Corporation, Synbiotics Corporation, Eurovet Animal Health B.V., Abaxis Inc., and Putney Inc.

A notable development occurred in July 2024 when Dechra Pharmaceuticals Limited, a UK-based veterinary pharmaceutical provider, acquired Invetx Inc., a US company specializing in protein-based therapeutic biologics for companion animals. This strategic acquisition broadened Dechra's companion animal pharmaceuticals portfolio, especially enhancing its position in high-growth biologics by including innovative monoclonal antibody treatments for chronic diseases in cats and dogs.

View the full companion animal pharmaceuticals market report:
https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Current Trends and Innovations Driving the Companion Animal Pharmaceuticals Sector
To capture wider markets and increase sales, leading companies are focusing on launching novel products such as oral flea and tick medications. These oral treatments help prevent or manage infestations common in pets. For example, in October 2024, Elanco Animal Health Incorporated received FDA approval for Credelio Quattro, a new chewable parasiticide for dogs. This product provides monthly protection against six different parasites, including fleas, ticks, and multiple internal worms. With this offering, Elanco is addressing the need for comprehensive, convenient parasite control solutions, reflecting the company's commitment to advancing pet health innovations.

Additional emerging trends emphasize personalized care, ensuring medications are specifically formulated to suit the unique needs of different companion animal species, along with increasing distribution through veterinary clinics, retail pharmacies, and online platforms to improve accessibility for pet owners.

Detailed Segmentation of the Companion Animal Pharmaceuticals Market
This market is divided into several key segments for a thorough understanding:

1) Product Type: Therapeutic Drugs, Vaccines, and Other Product Types
2) Animal Type: Dogs, Cats, Equines, and Other Animals
3) Route of Administration: Oral, Injectable, Topical, Inhalation, and Other Routes
4) Distribution Channel: Veterinary Hospitals and Clinics, Retail Pharmacies, Online Pharmacies or E-commerce, Veterinary Distributors, and Direct Sales
5) End Users: Veterinarians, Pet Owners, Animal Care Centers, and Pet Specialty Stores

Further subcategories include:
- Therapeutic Drugs: Anti-infectives, Cardiovascular Drugs, Hormonal and Metabolic Drugs, Dermatological Drugs, Pain Relief and Anti-inflammatory Drugs, Gastrointestinal Drugs, Respiratory Drugs, and Central Nervous System (CNS) Drugs
- Vaccines: Bacterial Vaccines, Viral Vaccines, and Combination Vaccines
- Other Product Types: Nutraceuticals and Supplements, Specialty Pharmaceuticals

This comprehensive segmentation highlights the diverse range of products and delivery methods designed to meet the specific healthcare needs of companion animals, reflecting the market's complexity and growth potential.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Drivers Analysis: The Rapid Evolution of the Companion Animal Pharmaceuticals Market here

News-ID: 4457619 • Views:

More Releases from The Business Research Company

Overview of the Pet Care E-commerce Market: Key Trends, Market Structure, and Major Players Analysis
Overview of the Pet Care E-commerce Market: Key Trends, Market Structure, and Ma …
The pet care e-commerce sector is on track for impressive expansion, reflecting shifting consumer behaviors and technological advancements. As more pet owners turn to online platforms for their pets' needs, this market is set to evolve rapidly, driven by innovation and a growing focus on premium and personalized products. Let's explore the current market size, key players, emerging trends, and segment details shaping this dynamic industry. Pet Care E-commerce Market Size
Leading Companies Reinforcing Their Presence in the Microorganism Feed Carbohydrase Market
Leading Companies Reinforcing Their Presence in the Microorganism Feed Carbohydr …
The microorganism feed carbohydrase market is set for significant expansion in the coming years as demand for sustainable and efficient animal nutrition solutions intensifies. This sector is evolving rapidly with innovations aimed at enhancing feed digestibility, optimizing gut health, and reducing reliance on antibiotics. Below, we explore the market's size, key players, emerging trends, and the segments that are shaping its growth trajectory. Strong Growth Outlook for the Microorganism Feed Carbohydrase
Global Drivers Analysis: The Rapid Evolution of the Frozen and Freeze-Dried Pet Food Market
Global Drivers Analysis: The Rapid Evolution of the Frozen and Freeze-Dried Pet …
The frozen and freeze-dried pet food sector is set to experience significant expansion over the coming years, driven by shifting consumer preferences and technological improvements. This evolving market is responding to pet owners' growing interest in high-quality, health-focused nutrition options for their animals. Below is a detailed overview of its current status, key players, market drivers, trends, segmentation, and regional outlook. Anticipated Growth Trajectory of the Frozen and Freeze-Dried Pet Food
Feed Micronutrients Market Overview, Current Trends, and Key Player Analysis
Feed Micronutrients Market Overview, Current Trends, and Key Player Analysis
The feed micronutrients industry is gaining considerable attention as it evolves to meet the growing demands of modern animal nutrition. Innovations in feed formulations and a stronger emphasis on sustainable and functional additives are driving this sector's expansion. Here, we explore the current market value, key players, notable trends, and segmentation to provide a comprehensive overview of this dynamic industry. Forecasted Market Value and Growth Trajectory of the Feed Micronutrients Market

All 5 Releases


More Releases for Animal

Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market. Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708 Farm Animals and Companion Animals are the
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report